Clinical Trials List
2020-05-29 - 2025-06-12
Phase III
Recruiting9
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chern-En Chiang 醫學研究部
- Harn-Shen Chen Division of Endocrinology
- 陳涵栩 Division of Endocrinology
- Wen-Chung Yu Division of Cardiovascular Diseases
- 吳承學 Division of General Internal Medicine
- Kang-Ling Wang 醫學研究部
- 黃少嵩 Division of Family Medicine
- Chin-Sung Kuo Division of Endocrinology
- Tse-Min Lu Division of Family Medicine
- Hao-min Cheng 教學部
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡易婷 Division of Endocrinology
- 鄭由承 Division of Endocrinology
- 梁凱偉 Division of Cardiovascular Diseases
- 許惠恒 Division of Endocrinology
- 傅家保 Division of Endocrinology
- JUN-SING WANG Division of Endocrinology
- 張之昀 Division of Endocrinology
- 沈宜靜 Division of Endocrinology
- 李宇璇 Division of Endocrinology
- 陳彥銘 Division of Endocrinology
- 王奇彥 Division of Cardiovascular Diseases
- 林時逸 Division of Geriatrics
- 李佳霖 Division of Endocrinology
- 陳威麟 Division of Endocrinology
- Yu-Cheng Hsieh Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林志展 Division of Cardiovascular Diseases
- Horng-Yih Ou Division of Endocrinology
- Hao-Chang Hung Division of Endocrinology
- 李文煌 Division of Cardiovascular Diseases
- 陳柏偉 Division of Cardiovascular Diseases
- 林景翰 Division of Endocrinology
- Po-Sheng Chen Division of Cardiovascular Diseases
- 杜業豐 Division of Endocrinology
- Cheng-Han Lee Division of Cardiovascular Diseases
- Yen-Wen Liu Division of Cardiovascular Diseases
- Po-Tseng Lee Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
90-180 participants
-
Global
13299 participants